ShcA Protects against Epithelial–Mesenchymal Transition through Compartmentalized Inhibition of TGF-β-Induced Smad Activation

Epithelial–mesenchymal transition (EMT) is a normal cell differentiation event during development and contributes pathologically to carcinoma and fibrosis progression. EMT often associates with increased transforming growth factor-β (TGF-β) signaling, and TGF-β drives EMT, in part through Smad-mediated reprogramming of gene expression. TGF-β also activates the Erk MAPK pathway through recruitment and Tyr phosphorylation of the adaptor protein ShcA by the activated TGF-β type I receptor. We found that ShcA protects the epithelial integrity of nontransformed cells against EMT by repressing TGF-β-induced, Smad-mediated gene expression. p52ShcA competed with Smad3 for TGF-β receptor binding, and down-regulation of ShcA expression enhanced autocrine TGF-β/Smad signaling and target gene expression, whereas increased p52ShcA expression resulted in decreased Smad3 binding to the TGF-β receptor, decreased Smad3 activation, and increased Erk MAPK and Akt signaling. Furthermore, p52ShcA sequestered TGF-β receptor complexes to caveolin-associated membrane compartments, and reducing ShcA expression enhanced the receptor localization in clathrin-associated membrane compartments that enable Smad activation. Consequently, silencing ShcA expression induced EMT, with increased cell migration, invasion, and dissemination, and increased stem cell generation and mammosphere formation, dependent upon autocrine TGF-β signaling. These findings position ShcA as a determinant of the epithelial phenotype by repressing TGF-β-induced Smad activation through differential partitioning of receptor complexes at the cell surface.

[1]  Shireen Khan,et al.  Development and characterization of human monoclonal antibodies that neutralize multiple TGFβ isoforms , 2015, mAbs.

[2]  L. McCaffrey,et al.  Atypical protein kinase C induces cell transformation by disrupting Hippo/Yap signaling , 2015, Molecular biology of the cell.

[3]  R. Derynck,et al.  The insulin response integrates increased TGF-β signaling through Akt-induced enhancement of cell surface delivery of TGF-β receptors , 2015, Science Signaling.

[4]  R. Derynck,et al.  Signaling pathway cooperation in TGF-β-induced epithelial-mesenchymal transition. , 2014, Current opinion in cell biology.

[5]  D. Medici,et al.  Signaling mechanisms of the epithelial-mesenchymal transition , 2014, Science Signaling.

[6]  Morag Park,et al.  p66ShcA Promotes Breast Cancer Plasticity by Inducing an Epithelial-to-Mesenchymal Transition , 2014, Molecular and Cellular Biology.

[7]  Y. Henis,et al.  Dab2 inhibits the cholesterol-dependent activation of JNK by TGF-β , 2014, Molecular Biology of the Cell.

[8]  Samy Lamouille,et al.  Molecular mechanisms of epithelial–mesenchymal transition , 2014, Nature Reviews Molecular Cell Biology.

[9]  Shuning He,et al.  Transforming growth factor-β signalling controls human breast cancer metastasis in a zebrafish xenograft model , 2013, Breast Cancer Research.

[10]  Ursula Pieper,et al.  A role for matrix metalloproteinases in regulating mammary stem cell function via the Wnt signaling pathway. , 2013, Cell stem cell.

[11]  T. Pawson,et al.  The ShcA PTB domain functions as a biological sensor of phosphotyrosine signaling during breast cancer progression. , 2013, Cancer research.

[12]  Tony Pawson,et al.  Temporal regulation of EGF signaling networks by the scaffold protein Shc1 , 2013, Nature.

[13]  S. Arold,et al.  Interaction with Shc prevents aberrant Erk activation in the absence of extracellular stimuli , 2013, Nature Structural &Molecular Biology.

[14]  Robert G. Parton,et al.  Caveolae as plasma membrane sensors, protectors and organizers , 2013, Nature Reviews Molecular Cell Biology.

[15]  Samy Lamouille,et al.  TGF-&bgr; signaling and epithelial–mesenchymal transition in cancer progression , 2013, Current opinion in oncology.

[16]  T. Pawson,et al.  The ShcA SH2 domain engages a 14-3-3/PI3′K signaling complex and promotes breast cancer cell survival , 2012, Oncogene.

[17]  Nina Jones,et al.  Teaching an old dogma new tricks: twenty years of Shc adaptor signalling. , 2012, The Biochemical journal.

[18]  C. Heldin,et al.  Induction of epithelial-mesenchymal transition by transforming growth factor β. , 2012, Seminars in cancer biology.

[19]  R. Weinberg,et al.  Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. , 2012, Seminars in cancer biology.

[20]  J. Massagué.  TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.

[21]  Andrea I. McClatchey,et al.  Spatial regulation of receptor tyrosine kinases in development and cancer , 2012, Nature Reviews Cancer.

[22]  James W. Smyth,et al.  TGF-β-induced activation of mTOR complex 2 drives epithelial–mesenchymal transition and cell invasion , 2012, Journal of Cell Science.

[23]  Luzhe Sun,et al.  Mutant p53 Disrupts Role of ShcA Protein in Balancing Smad Protein-dependent and -independent Signaling Activity of Transforming Growth Factor-β (TGF-β)* , 2011, The Journal of Biological Chemistry.

[24]  C. Meyer,et al.  Distinct role of endocytosis for Smad and non-Smad TGF-β signaling regulation in hepatocytes. , 2011, Journal of hepatology.

[25]  Harvey T. McMahon,et al.  Molecular mechanism and physiological functions of clathrin-mediated endocytosis , 2011, Nature Reviews Molecular Cell Biology.

[26]  H. Chapman,et al.  Epithelial-mesenchymal interactions in pulmonary fibrosis. , 2011, Annual review of physiology.

[27]  E. Lundberg,et al.  Towards a knowledge-based Human Protein Atlas , 2010, Nature Biotechnology.

[28]  K. Burg,et al.  Matrix compositions and the development of breast acini and ducts in 3D cultures , 2010, In Vitro Cellular & Developmental Biology - Animal.

[29]  Kohei Miyazono,et al.  TGFβ signalling: a complex web in cancer progression , 2010, Nature Reviews Cancer.

[30]  Marilyn Goudreault,et al.  The PTB domain of ShcA couples receptor activation to the cytoskeletal regulator IQGAP1 , 2010, The EMBO journal.

[31]  M. Rajendran,et al.  p66Shc—a longevity redox protein in human prostate cancer progression and metastasis , 2010, Cancer and Metastasis Reviews.

[32]  R. Huang,et al.  Epithelial-Mesenchymal Transitions in Development and Disease , 2009, Cell.

[33]  R. Derynck,et al.  Essential role of TGF-beta signaling in glucose-induced cell hypertrophy. , 2009, Developmental cell.

[34]  Raghu Kalluri,et al.  The basics of epithelial-mesenchymal transition. , 2009, The Journal of clinical investigation.

[35]  Ye Guang Chen,et al.  Specific Activation of Mitogen-activated Protein Kinase by Transforming Growth Factor-␤ Receptors in Lipid Rafts Is Required for Epithelial Cell Plasticity Transforming Growth Factor (tgf)-␤ Regulates a Spectrum of Cellular Events, including Cell Proliferation, Differentiation, and Migration. in Add , 2008 .

[36]  Y. Radhakrishnan,et al.  Insulin-like Growth Factor-I Stimulates Shc-dependent Phosphatidylinositol 3-Kinase Activation via Grb2-associated p85 in Vascular Smooth Muscle Cells* , 2008, Journal of Biological Chemistry.

[37]  R. Derynck,et al.  The type I TGF-β receptor is covalently modified and regulated by sumoylation , 2008, Nature Cell Biology.

[38]  Wenjun Guo,et al.  The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells , 2008, Cell.

[39]  T. Pawson,et al.  ShcA signalling is essential for tumour progression in mouse models of human breast cancer , 2008, The EMBO journal.

[40]  W. Muller,et al.  Signaling through ShcA Is Required for Transforming Growth Factor β- and Neu/ErbB-2-Induced Breast Cancer Cell Motility and Invasion , 2008, Molecular and Cellular Biology.

[41]  Jing Qing,et al.  TGF‐β activates Erk MAP kinase signalling through direct phosphorylation of ShcA , 2007 .

[42]  Samy Lamouille,et al.  Cell size and invasion in TGF-β–induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway , 2007, The Journal of cell biology.

[43]  C. Waterman-Storer,et al.  Caveolin-1 regulates cell polarization and directional migration through Src kinase and Rho GTPases , 2007, The Journal of cell biology.

[44]  R. Philp,et al.  PKC δ phosphorylates p52ShcA at Ser29 to regulate ERK activation in response to H2O2 , 2007 .

[45]  Haiyan I. Li,et al.  Purification and unique properties of mammary epithelial stem cells , 2006, Nature.

[46]  R. Derynck,et al.  SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .

[47]  C. Heldin,et al.  Non-Smad TGF-β signals , 2005, Journal of Cell Science.

[48]  S. Goff,et al.  ERK phosphorylates p66shcA on Ser36 and subsequently regulates p27kip1 expression via the Akt-FOXO3a pathway: implication of p27kip1 in cell response to oxidative stress. , 2005, Molecular biology of the cell.

[49]  C. Heldin,et al.  TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. , 2005, Molecular biology of the cell.

[50]  H. Moses,et al.  Activation of the Erk pathway is required for TGF-beta1-induced EMT in vitro. , 2004, Neoplasia.

[51]  P. Pelicci,et al.  p66SHC Promotes Apoptosis and Antagonizes Mitogenic Signaling in T Cells , 2004, Molecular and Cellular Biology.

[52]  R. Cordera,et al.  Specificity of insulin-like growth factor I and insulin on Shc phosphorylation and Grb2 recruitment in caveolae. , 2003, Endocrinology.

[53]  Ying E. Zhang,et al.  Smad-dependent and Smad-independent pathways in TGF-β family signalling , 2003, Nature.

[54]  M. Vieth,et al.  Synthesis and activity of new aryl- and heteroaryl-substituted pyrazole inhibitors of the transforming growth factor-beta type I receptor kinase domain. , 2003, Journal of medicinal chemistry.

[55]  J. Massagué,et al.  Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus , 2003, Cell.

[56]  G. Dontu,et al.  In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. , 2003, Genes & development.

[57]  Jeffrey L. Wrana,et al.  Distinct endocytic pathways regulate TGF-β receptor signalling and turnover , 2003, Nature Cell Biology.

[58]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[59]  Yoav I. Henis,et al.  Transforming growth factor-beta receptors interact with AP2 by direct binding to beta2 subunit. , 2002, Molecular biology of the cell.

[60]  P. Pelicci,et al.  The Neuron-Specific Rai (ShcC) Adaptor Protein Inhibits Apoptosis by Coupling Ret to the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway , 2002, Molecular and Cellular Biology.

[61]  A. Faisal,et al.  Serine/Threonine Phosphorylation of ShcA , 2002, The Journal of Biological Chemistry.

[62]  J. Doré,et al.  Internalization-Dependent and -Independent Requirements for Transforming Growth Factor β Receptor Signaling via the Smad Pathway , 2002, Molecular and Cellular Biology.

[63]  A. Reith,et al.  SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.

[64]  Malgorzata Kisielow,et al.  Isoform-specific knockdown and expression of adaptor protein ShcA using small interfering RNA. , 2002, The Biochemical journal.

[65]  Kodi S Ravichandran,et al.  Signaling via Shc family adapter proteins , 2001, Oncogene.

[66]  M. Bitzer,et al.  Caveolin-1 Regulates Transforming Growth Factor (TGF)-β/SMAD Signaling through an Interaction with the TGF-β Type I Receptor* , 2001, The Journal of Biological Chemistry.

[67]  P. Pelicci,et al.  Evolution of Shc functions from nematode to human. , 2000, Current opinion in genetics & development.

[68]  H. Moses,et al.  Phosphatidylinositol 3-Kinase Function Is Required for Transforming Growth Factor β-mediated Epithelial to Mesenchymal Transition and Cell Migration* , 2000, The Journal of Biological Chemistry.

[69]  T Pawson,et al.  The ShcA phosphotyrosine docking protein sensitizes cardiovascular signaling in the mouse embryo. , 2000, Genes & development.

[70]  Pier Paolo Pandolfi,et al.  The p66shc adaptor protein controls oxidative stress response and life span in mammals , 1999, Nature.

[71]  E. Reddy,et al.  Signaling by dual specificity kinases , 1998, Oncogene.

[72]  J. Smith,et al.  Insulin-induced protein tyrosine phosphorylation cascade and signalling molecules are localized in a caveolin-enriched cell membrane domain. , 1998, Cellular signalling.

[73]  K. Kinzler,et al.  Human Smad3 and Smad4 are sequence-specific transcription activators. , 1998, Molecular cell.

[74]  Kenneth M. Yamada,et al.  The Zinc-Finger Protein Slug Causes Desmosome Dissociation, an Initial and Necessary Step for Growth Factor–induced Epithelial–Mesenchymal Transition , 1997, The Journal of cell biology.

[75]  R. Derynck,et al.  The Type II Transforming Growth Factor-β Receptor Autophosphorylates Not Only on Serine and Threonine but Also on Tyrosine Residues* , 1997, The Journal of Biological Chemistry.

[76]  G. Superti-Furga,et al.  Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor–MAP kinase–fos signalling pathway , 1997, The EMBO journal.

[77]  R. Derynck,et al.  Receptor-associated Mad homologues synergize as effectors of the TGF-β response , 1996, Nature.

[78]  R. Derynck,et al.  Transforming Growth Factor-β (TGF-β)-induced Down-regulation of Cyclin A Expression Requires a Functional TGF-β Receptor Complex , 1995, The Journal of Biological Chemistry.

[79]  T. Pawson,et al.  A Drosophila shc gene product is implicated in signaling by the DER receptor tyrosine kinase , 1995, Molecular and cellular biology.

[80]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  R. Derynck,et al.  TGF-beta induced transdifferentiation of mammary epithelial cells to mesenchymal cells: involvement of type I receptors , 1994, The Journal of cell biology.

[82]  S. Inui,et al.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct , 1994 .

[83]  M. Lazzara,et al.  ERK1/2 blockade prevents epithelial-mesenchymal transition in lung cancer cells and promotes their sensitivity to EGFR inhibition. , 2014, Cancer research.

[84]  Cécile Boscher,et al.  Caveolin-1: role in cell signaling. , 2012, Advances in experimental medicine and biology.

[85]  Samy Lamouille,et al.  TACE-Mediated Ectodomain Shedding of the Type I TGF-b Receptor Downregulates TGF-b Signaling , 2009 .

[86]  Ying E Zhang,et al.  Non-Smad pathways in TGF-β signaling , 2009, Cell Research.

[87]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.